Neils Scott C reported tax withholding involving 28,155 shares of Xtant Medical Holdings, Inc. at $0.31 for −$8.73k on Aug 15, 2026

Tax withholding
Form 4 code F. Payment of an exercise price or tax liability by delivering or withholding securities in a Rule 16b-3 transaction.
CFO and Assistant Secretary
CFO and Assistant Secretary
Filed Aug 18, 2026

Facts from the filing

Form 4 · Non-derivative, table I
Disclosed value
−$8,728.05Shares × reported price
Shares traded
28,155Common Stock
Price per share
$0.31Reported price. Read footnotes for ranges.
% of reported position traded
UnavailableThis security and ownership context
Holdings after
1,215,226Direct
Trade date
Aug 15, 2026Tax withholding
Filed
Aug 18, 2026, 5:54 PM ET3-day reporting delay
Accession
0001902610-26-000002Code F · Transaction 3976
How reported position traded is calculated

Calculated only for code-P purchases and code-S sales.

Row-level estimate for this security and ownership context, not the insider’s complete portfolio. Joint ownership, other transactions in the filing, amendments and footnotes can affect interpretation.

Other trades in this filing

Trade dateActivitySharesPriceValueDetails
Aug 15, 2026Grant400,000$0.00$0Trade 3975
2 transaction rows in this filing. Joint filers share the same rows.

XTNT price since this filing

Daily closing prices, with the filing date and available return windows. Return methodology
XTNT · Daily closing priceDaily price data is pending. The chart appears when valid daily closes are available.
Filing dateReturn windows appear as prices become available.
Pre-filing1mo ago +33%1w ago +33%1d ago −9.1%
Returns since7d −6.1%30d −3%90d180d1y

Footnotes in full

F1: These shares will vest with respect to 100,000 shares on each of August 15, 2027, August 15, 2028, August 15, 2029, and August 15, 2030 pursuant to a deferred stock unit (DSU) award granted under the Xtant Medical Holdings, Inc. Amended and Restated 2023 Equity Incentive Plan, conditioned upon the Reporting Person remaining an employee of Xtant through the applicable vesting date. The settlement of the vested shares underlying the DSU award has been deferred and will occur at a later date pursuant to the terms of the DSU award agreement. Each DSU represents a contingent right to receive one share of the Issuer's common stock. F2: Includes an aggregate of 869,878 shares issuable upon vesting and settlement of restricted stock unit awards or DSU awards granted under the Xtant Medical Holdings, Inc. Amended and Restated 2023 Equity Incentive Plan conditioned upon the Reporting Person remaining an employee of Xtant through the respective vesting dates. F3: These shares were withheld by the Issuer to pay tax withholding obligations upon vesting and settlement of restricted stock unit awards.